Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-20-005240)

Filing Details

Accession Number:: 0001179110-20-005240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-29 17:13:25
Reporting Period:: 2020-04-27

Accepted Time:: 2020-04-29 17:13:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775522	Brent Neidig	3838 West Parkway Blvd. West Valley City UT 84120	Chief Officer & Md Of China	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-04-27	1,831	$84.75	0	No	4	S	Direct
Common Stock	Acquisiton	2020-04-29	468	$0.00	468	No	4	M	Direct
Common Stock	Disposition	2020-04-29	208	$87.64	260	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-04-29	468	$0.00	468	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,163			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
On April 29th, 2019, the reporting person was granted 1,870 restricted stock units, vesting at 25% on each 29th of April thereafter.